King Christopher R, Fritz Bradley A, Gregory Stephen H, Budelier Thaddeus P, Ben Abdallah Arbi, Kronzer Alex, Helsten Daniel L, Torres Brian, McKinnon Sherry L, Tripathi Sandhya, Abdelhack Mohamed, Goswami Shreya, Montes de Oca Arianna, Mehta Divya, Valdez Miguel A, Karanikolas Evangelos, Higo Omokhaye, Kerby Paul, Henrichs Bernadette, Wildes Troy S, Politi Mary C, Abraham Joanna, Avidan Michael S, Kannampallil Thomas
Department of Anesthesiology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.
Department of Anesthesiology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.
Br J Anaesth. 2025 Mar;134(3):671-680. doi: 10.1016/j.bja.2024.11.017. Epub 2025 Jan 3.
Telemedicine may help improve care quality and patient outcomes. Telemedicine for intraoperative decision support has not been rigorously studied.
This was a single-centre randomised clinical trial of unselected adult surgical patients. Patients were randomised to receive usual care or decision support from a telemedicine service, which provided real-time recommendations to intraoperative anaesthesia clinicians based on case reviews and physiological alerts. ORs were randomised 1:1. The co-primary outcomes were 30-day all-cause mortality, respiratory failure, acute kidney injury, and delirium in the intensive care unit, analysed by intention to treat.
Between July 1, 2019, and January 31, 2023, a total of 35,302 patients were randomised to receive telemedicine support, with 36,625 receiving usual care. Telemedicine clinicians provided review in 11,812/35,302 cases, with alerts delivered to 2044/35,302 patients. Telemedicine support had no effect on any of the co-primary outcomes. Within 30 days, 630/35,302 (1.8%) patients randomised to telemedicine died within 30 days, compared with 649/36,625 (1.8%) receiving usual care (relative risk [RR]1.01, 95% confidence interval [CI] 0.87-1.16, P=0.98). Telemedicine support did not alter postoperative respiratory failure [telemedicine 1071/33,996 (3.2%) vs usual care 1130/35,236 (3.2%), RR 0.98, 95% CI 0.88-1.09, P=0.98], acute kidney injury [telemedicine 2316/33 251 (7.0%) vs usual care 2432/34,441 (7.1%); RR 0.99, 95% CI 0.92-1.06, P=0.98], or delirium [telemedicine 1264/3873 (32.6%) vs usual care 1298/4044 (32.1%), RR 1.02, 95% CI 0.94-1.10, P=0.98].
In this large randomised clinical trial, intraoperative telemedicine decision support using real-time alerts and case reviews had no impact on adverse postoperative outcomes.
NCT03923699.
远程医疗可能有助于提高医疗质量和患者预后。术中决策支持的远程医疗尚未得到严格研究。
这是一项针对未选择的成年外科患者的单中心随机临床试验。患者被随机分配接受常规护理或远程医疗服务的决策支持,该服务根据病例审查和生理警报为术中麻醉临床医生提供实时建议。手术病例按1:1随机分配。共同主要结局为30天全因死亡率、呼吸衰竭、急性肾损伤和重症监护病房中的谵妄,采用意向性分析。
在2019年7月1日至2023年1月31日期间,共有35302例患者被随机分配接受远程医疗支持,36625例接受常规护理。远程医疗临床医生对11812/35302例病例进行了审查,向2044/35302例患者发出了警报。远程医疗支持对任何一项共同主要结局均无影响。30天内,随机分配至远程医疗组的35302例患者中有630例(1.8%)在30天内死亡,接受常规护理的36625例患者中有649例(1.8%)死亡(相对风险[RR]1.01,95%置信区间[CI]0.87 - 1.16,P = 0.98)。远程医疗支持未改变术后呼吸衰竭[远程医疗组1071/33996例(3.2%),常规护理组1130/35236例(3.2%),RR 0.98,95%CI 0.88 - 1.09,P = 0.98]、急性肾损伤[远程医疗组2316/33251例(7.0%),常规护理组2432/34441例(7.1%);RR 0.99,95%CI 0.92 - 1.06,P = 0.98]或谵妄[远程医疗组1264/3873例(32.6%),常规护理组1298/4044例(32.1%),RR 1.02,95%CI 0.94 - 1.10,P = 0.98]。
在这项大型随机临床试验中,使用实时警报和病例审查的术中远程医疗决策支持对术后不良结局无影响。
NCT03923699